Jailati, Elnie .
HRN: 23-15-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2023
OXACILLIN 500MG (VIAL)
06/10/2023
06/16/2023
IV DRIP
115 Mg
Q6
Bacterial Skin Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes